Scientific Advisory Board
Carlos Bustamante, PhD
Professor in the Department of Genetics at the Stanford University School of Medicine
He is also the inaugural chair of the Department of Biomedical Data Science at Stanford. Dr. Bustamante is a MacArthur Fellow and was recently named as a Chan-Zuckerberg Biohub Investigator. Dr. Bustamante’s current research focuses on human population genomics and global health including developing statistical, computational, and genomic resources for enabling trans- and multi-ethnic genome-wide association and medical sequencing studies of complex biomedical traits.
David Sinclair, PhD
Professor in the Department of Genetics at Harvard Medical School
He is also the co-Director of the Paul F. Glenn Center for the Biological Mechanisms of Aging. He is best known for his work on understanding why we age and how to slow its effects. Dr. Sinclair is a co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging.
David Relman, MD
Thomas C. and Joan M. Merigan Professor in Medicine, and Microbiology & Immunology, and Co-Director of the Center for International Security and Cooperation at Stanford University
He is also Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. Dr. Relman’s research focus is the human indigenous microbiota, and the identification of previously-unrecognized microbial agents of disease. He has advised the U.S. Government on emerging infectious diseases, human-microbe interactions, and future biological threats.
Ami Bhatt, MD, PhD
Assistant Professor of Medicine (Hematology) and Genetics at Stanford University
Dr. Bhatt’s group works to identify problems and questions that arise in the course of routine clinical care through the use of modern genetic, molecular and computational techniques. She seeks to exhaustively characterize the dynamics of the microbiota and environmental pathogens in immunocompromised and underserved populations and to explore how changes in the microbiome are associated with diseases in these populations.
Chris Mason, PhD
Associate Professor at Weill Cornell Medicine
He also has appointments at the Tri-Institutional Program in Computational Biology and Medicine between Cornell, Memorial Sloan-Kettering Cancer Center and Rockefeller University, the Sandra and Edward Meyer Cancer Center, and the Feil Family Brain and Mind Research Institute. His lab develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and human physiology.
David Pryor, MD
Executive Vice President and Chief Clinical Officer at Ascension Health
In this role, he provides the senior clinical leadership across Ascension. He also provides the senior leadership for the Ascension Clinical Research Initiative. From 2001 to 2011 he was the Chief Medical Officer of Ascension Health, the largest not-for-profit healthcare delivery system in the U.S.
Beth Shapiro, PhD
Associate Professor in the Department of Ecology & Evolutionary Biology at UC Santa Cruz
She was also selected as a MacArthur fellow in 2009. Dr. Shapiro’s research aims to better understand how populations and species change through time, particularly in response to environmental and other changes to their habitat using the latest experimental and computational approaches to analyze genetic information isolated from fossil and archived remains.
Dan Rokshar, PhD
Professor of Genetics, Genomics and Development at the University of California at Berkley
Dr. Rokhsar’s research is focused on understanding the origin, evolution, and diversity of animals (and, more generally, other groups of eukaryotes) by combining computational genome analysis with comparative developmental biology. He is a specialist in de novo genome assembly.
Richard "Ed" Green, PhD
Assistant Professor in the Department of Biomolecular Engineering at UC Santa Cruz
He led the project to sequence the first Neandertal genome in 2008, and he has extensive expertise in genomics and computational molecular biology. He is also President of Dovetail Genomics, a company that is commercializing Dr. Green’s work developing an in vitro method for constructing mate-pair libraries whose inserts span all distances up to the size of the input DNA.
Yaniv Erlich, PhD
Assistant Professor of Computer Science and Computational Biology at Columbia University
He is also a core member at the New York Genome Center and is currently CSO of MyHeritage. Dr. Erlich’s research interests revolve around computational human genetics.
An avid inventor experienced R&D leader, a biotech executive, entrepreneur, and active member of his community. Bob retired from Illumina in 2014 after 14 years as Chief Engineering Officer. Prior to joining Illumina, Bob was the Director of the Microarray Business Unit at Molecular Dynamics.